Home LiteratureArticle Details
PMID: 10639352 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Multiple antibiotic resistance in Stenotrophomonas maltophilia: involvement of a multidrug efflux system.

Antimicrobial agents and chemotherapy ·Vol. 44 ·No. 2 ·2000-02-00 ·Pages 287-93

Zhang L, Li XZ, Poole K

Abstract

Clinical strains of Stenotrophomonas maltophilia are often highly resistant to multiple antibiotics, although the mechanisms of resistance are generally poorly understood. Multidrug resistant (MDR) strains were readily selected by plating a sensitive reference strain of the organism individually onto a variety of antibiotics, including tetracycline, chloramphenicol, ciprofloxacin, and norfloxacin. Tetracycline-selected MDR strains typically showed cross-resistance to erythromycin and fluoroquinolones and, in some instances, aminoglycosides. MDR mutants selected with the other agents generally displayed resistance to chloramphenicol and fluoroquinolones only, although two MDR strains (e.g., K1385) were also resistant to erythromycin and hypersusceptible to aminoglycosides. Many of the MDR strains expressed either moderate or high levels of a novel outer membrane protein (OMP) of ca. 50 kDa molecular mass, a phenotype typical of MDR strains of Pseudomonas aeruginosa hyperexpressing drug efflux systems. Indeed, the 50-kDa OMP of these S. maltophilia MDR strains reacted with antibody to OprM, the outer membrane component of the MexAB-OprM MDR efflux system of P. aeruginosa. Similarly, a ca. 110-kDa cytoplasmic membrane protein of these MDR strains also reacted with antibody to the MexB component of the P. aeruginosa pump. The outer and cytoplasmic membranes of several clinical S. maltophilia strains also reacted with the anti-OprM and anti-MexB antibodies. N-terminal amino acid sequencing of a cyanogen bromide-generated peptide of the 50-kDa OMP of MDR strain K1385, dubbed SmeM (Stenotrophomonas multidrug efflux), revealed it to be very similar to a number of outer membrane multidrug efflux components of P. aeruginosa and Pseudomonas putida. Deletion of the L1 and L2 beta-lactamase genes confirmed that these enzymes were responsible for the bulk of the beta-lactam resistance of K1385 and its parent. Still, overexpression of the MDR efflux mechanism in an L1- and L2-deficient derivative of K1385 did yield a modest increase in resistance to a few beta-lactams. These data are consistent with the MDR efflux mechanism(s) playing a role in the multidrug resistance of S. maltophilia.

MeSH Terms
Anti-Bacterial Agents/metabolism,pharmacology Bacterial Proteins/metabolism Biological Transport Drug Resistance, Microbial/physiology Drug Resistance, Multiple Humans Microbial Sensitivity Tests Stenotrophomonas maltophilia/drug effects,isolation & purification,metabolism beta-Lactamases/metabolism beta-Lactams
Chemicals
Anti-Bacterial Agents Bacterial Proteins beta-Lactams beta-Lactamases
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Zhang L
Department of Microbiology and Immunology, Queen's University, Kingston, Ontario K7L 3N6, Canada.
Li X Z
Poole K
References (44)
44 references, click to expand
  1. Bacteremia due to multiresistant gram-negative bacilli in neutropenic cancer patients: a case controlled study.
    J Chemother. 1998 Aug;10(4):320-5 PMID: 9720472
  2. Characterization of MexE-MexF-OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa.
    Mol Microbiol. 1997 Jan;23(2):345-54 PMID: 9044268
  3. Multidrug efflux pump AcrAB of Salmonella typhimurium excretes only those beta-lactam antibiotics containing lipophilic side chains.
    J Bacteriol. 1998 Sep;180(17):4686-92 PMID: 9721312
  4. An overview of the kinetic parameters of class B beta-lactamases.
    Biochem J. 1993 Apr 1;291 ( Pt 1):151-5 PMID: 8471035
  5. Beta-lactamase inhibitors are substrates for the multidrug efflux pumps of Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 1998 Feb;42(2):399-403 PMID: 9527793
  6. Overexpression, purification, and characterization of the cloned metallo-beta-lactamase L1 from Stenotrophomonas maltophilia.
    Antimicrob Agents Chemother. 1998 Apr;42(4):921-6 PMID: 9559809
  7. Molecular heterogeneity of the L-1 metallo-beta-lactamase family from Stenotrophomonas maltophilia.
    Antimicrob Agents Chemother. 1998 May;42(5):1245-8 PMID: 9593158
  8. Molecular epidemiology of Stenotrophomonas maltophilia isolated from clinical specimens from patients with cystic fibrosis and associated environmental samples.
    J Clin Microbiol. 1998 Jul;36(7):1953-8 PMID: 9650943
  9. Contribution of outer membrane efflux protein OprM to antibiotic resistance in Pseudomonas aeruginosa independent of MexAB.
    Antimicrob Agents Chemother. 1998 Jul;42(7):1682-8 PMID: 9661004
  10. A broad-host-range Flp-FRT recombination system for site-specific excision of chromosomally-located DNA sequences: application for isolation of unmarked Pseudomonas aeruginosa mutants.
    Gene. 1998 May 28;212(1):77-86 PMID: 9661666
  11. Microbiology of sputum from patients at cystic fibrosis centers in the United States.
    Clin Infect Dis. 1998 Jul;27(1):158-63 PMID: 9675470
  12. Characterization of the MexC-MexD-OprJ multidrug efflux system in DeltamexA-mexB-oprM mutants of Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 1998 Aug;42(8):1938-43 PMID: 9687387
  13. Clinical problems posed by multiresistant nonfermenting gram-negative pathogens.
    Clin Infect Dis. 1998 Aug;27 Suppl 1:S117-24 PMID: 9710680
  14. Solubilization of the cytoplasmic membrane of Escherichia coli by the ionic detergent sodium-lauryl sarcosinate.
    J Bacteriol. 1973 Sep;115(3):717-22 PMID: 4580564
  15. The use of analytical isoelectric focusing for detection and identification of beta-lactamases.
    J Gen Microbiol. 1975 May;88(1):169-78 PMID: 807678
  16. Electrophoretic resolution of the "major outer membrane protein" of Escherichia coli K12 into four bands.
    FEBS Lett. 1975 Oct 15;58(1):254-8 PMID: 773686
  17. Xanthomonas maltophilia: an emerging nosocomial pathogen.
    Mayo Clin Proc. 1989 Sep;64(9):1097-104 PMID: 2682049
  18. Susceptibility of Xanthomonas maltophilia to six quinolones and study of outer membrane proteins in resistant mutants selected in vitro.
    Antimicrob Agents Chemother. 1992 Mar;36(3):669-71 PMID: 1622183
  19. Cloning and nucleotide sequence analysis of the ferripyoverdine receptor gene fpvA of Pseudomonas aeruginosa.
    J Bacteriol. 1993 Aug;175(15):4597-604 PMID: 8335619
  20. Molecular cloning and characterization of acrA and acrE genes of Escherichia coli.
    J Bacteriol. 1993 Oct;175(19):6299-313 PMID: 8407802
  21. Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon.
    J Bacteriol. 1993 Nov;175(22):7363-72 PMID: 8226684
  22. A changing pattern of susceptibility of Xanthomonas maltophilia to antimicrobial agents: implications for therapy.
    Antimicrob Agents Chemother. 1994 Mar;38(3):624-7 PMID: 8203865
  23. Rapid identification of metallo- and serine beta-lactamases.
    Antimicrob Agents Chemother. 1994 May;38(5):991-6 PMID: 8067782
  24. Cloning and sequence analysis of an EnvCD homologue in Pseudomonas aeruginosa: regulation by iron and possible involvement in the secretion of the siderophore pyoverdine.
    Mol Microbiol. 1993 Nov;10(3):529-44 PMID: 7968531
  25. Mucocutaneous and soft tissue infections caused by Xanthomonas maltophilia. A new spectrum.
    Ann Intern Med. 1994 Dec 15;121(12):969-73 PMID: 7978724
  26. Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: active efflux as a contributing factor to beta-lactam resistance.
    Antimicrob Agents Chemother. 1994 Aug;38(8):1742-52 PMID: 7986004
  27. Role of mexA-mexB-oprM in antibiotic efflux in Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 1995 Sep;39(9):1948-53 PMID: 8540696
  28. Stenotrophomonas maltophilia in cystic fibrosis patients.
    Eur J Clin Microbiol Infect Dis. 1995 Aug;14(8):728-9 PMID: 8565998
  29. Xanthomonas maltophilia and Pseudomonas cepacia in lower respiratory tracts of patients in critical care units.
    J Infect. 1995 Sep;31(2):89-92 PMID: 8666858
  30. Stenotrophomonas (Xanthomonas) maltophilia urinary tract infection. A disease that is usually severe and complicated.
    Arch Intern Med. 1996 Feb 26;156(4):433-5 PMID: 8607729
  31. Quantitative correlation between susceptibility and OprJ production in NfxB mutants of Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 1996 Apr;40(4):909-13 PMID: 8849250
  32. Role of anti-pseudomonal antibiotics in the emergence of Stenotrophomonas maltophilia in cystic fibrosis patients.
    Eur J Clin Microbiol Infect Dis. 1996 May;15(5):402-5 PMID: 8793400
  33. Multidrug efflux pumps of gram-negative bacteria.
    J Bacteriol. 1996 Oct;178(20):5853-9 PMID: 8830678
  34. Bacteremia due to Stenotrophomonas (Xanthomonas) maltophilia: a prospective, multicenter study of 91 episodes.
    Clin Infect Dis. 1996 Mar;22(3):508-12 PMID: 8852971
  35. Overexpression of the mexC-mexD-oprJ efflux operon in nfxB-type multidrug-resistant strains of Pseudomonas aeruginosa.
    Mol Microbiol. 1996 Aug;21(4):713-24 PMID: 8878035
  36. Multiple antibiotic resistance in Stenotrophomonas maltophilia.
    Antimicrob Agents Chemother. 1997 May;41(5):1140-2 PMID: 9145884
  37. Risk factors associated with isolation of Stenotrophomonas (Xanthomonas) maltophilia in clinical specimens.
    Infect Control Hosp Epidemiol. 1997 May;18(5):316-21 PMID: 9154473
  38. Stenotrophomonas maltophilia meningitis. Report of two cases and review of the literature.
    J Neurosurg. 1997 Jul;87(1):106-8 PMID: 9202275
  39. Sequence analysis and enzyme kinetics of the L2 serine beta-lactamase from Stenotrophomonas maltophilia.
    Antimicrob Agents Chemother. 1997 Jul;41(7):1460-4 PMID: 9210666
  40. Inner membrane efflux components are responsible for beta-lactam specificity of multidrug efflux pumps in Pseudomonas aeruginosa.
    J Bacteriol. 1997 Dec;179(24):7875-81 PMID: 9401051
  41. Identification and molecular characterization of an efflux pump involved in Pseudomonas putida S12 solvent tolerance.
    J Biol Chem. 1998 Jan 2;273(1):85-91 PMID: 9417051
  42. Expression of Pseudomonas aeruginosa multidrug efflux pumps MexA-MexB-OprM and MexC-MexD-OprJ in a multidrug-sensitive Escherichia coli strain.
    Antimicrob Agents Chemother. 1998 Jan;42(1):65-71 PMID: 9449262
  43. Endocarditis caused by Stenotrophomonas maltophilia: case report and review.
    Clin Infect Dis. 1996 Dec;23(6):1261-5 PMID: 8953069
  44. Infective endocarditis due to Stenotrophomonas (Xanthomonas) maltophilia.
    Eur J Clin Microbiol Infect Dis. 1998 May;17(5):353-6 PMID: 9721966
Article Info
Journal
Antimicrobial agents and chemotherapy
Abbr.
Antimicrob Agents Chemother
ISSN
0066-4804
Published
2000-02-00
Pages
287-93
Language
English
Region
United States
NLM ID
0315061
PMCID
PMC89673
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com